CD274 and neoplasm: The current focus of cancer research in immune-modulating mechanisms mainly addresses the role of tumor-infiltrating immune cells as therapeutic targets (such as the PD1/PDL1 axis)15,16, representing the effector site of tumor promoting immunity.